The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ten, R. M.
Right arrow Articles by Paya, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ten, R. M.
Right arrow Articles by Paya, C. V.
The Journal of Immunology, 1999, 163: 3851-3857.
Copyright © 1999 by The American Association of Immunologists

The Signal Transduction Pathway of CD23 (Fc{epsilon}RIIb) Targets I{kappa}B Kinase1

Rosa M. Ten2,*, Melissa J. McKinstry*, Sergey A. Trushin{dagger}, Susana Asin{dagger} and Carlos V. Paya{dagger}

* Division of Allergy and {dagger} Department of Immunology, Mayo Clinic, Rochester, MN 55902

Alveolar macrophages play a crucial role in initiating the inflammatory response in allergic asthma through the cross-linking of the low affinity IgE receptors (Fc{epsilon}RIIb or CD23) by IgE-allergen immunocomplexes. We have previously shown that CD23 cross-linking in monocytes and U937 cells targets I{kappa}B{alpha}, leading to the activation of the transcription factor NF-{kappa}B. We demonstrate in this paper that CD23-initiated signaling in U937 cells leads to hyperphosphorylation of I{kappa}B{alpha} at Ser32/Ser36 residues. Overexpression of a dominant-negative I{kappa}B{alpha} transgene containing mutations at Ser32/Ser36 completely inhibits degradation of I{kappa}B{alpha}, NF-{kappa}B activation, and gene transcription that follows CD23 cross-linking. Investigation of the second messengers mediating the CD23-dependent activation of NF{kappa}B demonstrates that I{kappa}B kinases (IKKs) but not p90rsk are selectively activated following CD23 cross-linking and mediates the phosphorylation of I{kappa}B{alpha}. Cotransfection experiments with an IKKß negative dominant completely inhibit CD23 induced NF{kappa}B activation. Furthermore, the activation of tyrosine kinase(s) by CD23 is required for the induction of IKK activity, I{kappa}B{alpha} degradation, and NF-{kappa}B nuclear translocation. Taken together, our results show that CD23 cross-linking in the monocytic lineage induces tyrosine kinase activation followed by activation of IKK, which phosphorylates I{kappa}B{alpha} at the N-terminal domain (Ser32/Ser36), inducing its degradation, NF-{kappa}B activation and gene transcription.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Lebowitz, R. S. Edinger, B. An, C. J. Perry, S. Onate, T. R. Kleyman, and J. P. Johnson
I{kappa}B Kinase-{beta} (IKK{beta}) Modulation of Epithelial Sodium Channel Activity
J. Biol. Chem., October 1, 2004; 279(40): 41985 - 41990.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W.-C. Huang, J.-J. Chen, H. Inoue, and C.-C. Chen
Tyrosine Phosphorylation of I-{kappa}B Kinase {alpha}/{beta} by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-{alpha}-Induced Cyclooxygenase-2 Expression
J. Immunol., May 1, 2003; 170(9): 4767 - 4775.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-C. Huang, J.-J. Chen, and C.-C. Chen
c-Src-dependent Tyrosine Phosphorylation of IKKbeta Is Involved in Tumor Necrosis Factor-alpha -induced Intercellular Adhesion Molecule-1 Expression
J. Biol. Chem., March 7, 2003; 278(11): 9944 - 9952.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Wahl, F. Oswald, U. Simnacher, S. Weiss, R. Marre, and A. Essig
Survival of Chlamydia pneumoniae-Infected Mono Mac 6 Cells Is Dependent on NF-kappa B Binding Activity
Infect. Immun., November 1, 2001; 69(11): 7039 - 7045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.